Can methamphetamine improve performance? Controlled human research has documented improvements on selected laboratory tasks. A scientifically accurate account identifies the particular improvement and the conditions under which it occurred. It does not turn a positive result on one task into a claim about every aspect of human performance.
Four peer-reviewed studies illustrate this distinction. Each administered methamphetamine and reported a measured performance benefit, either on selected tasks or within a defined subgroup.
Hart and colleagues studied 11 experienced methamphetamine users in a double-blind, within-participant experiment. Participants received placebo and three intranasal doses: 12, 25, and 50 mg per 70 kg. All active doses improved tracking speed and response latency on a divided-attention task. The 12- and 25-mg doses also increased attempts and correct responses on a digit-symbol substitution task. Other performance measures showed no significant changes. These were controlled laboratory findings in experienced users, not a driving trial. [1]
Mahoney and colleagues studied 19 methamphetamine-dependent adults after a drug-free washout. Participants received saline and, the next day, 30 mg of intravenous methamphetamine in a single-blind design. The sample as a whole did not show a significant cognitive benefit. Participants classified as poorer baseline performers improved on selected attention and working-memory measures. Better baseline performers showed similar or decreased performance. The small sample, subgroup analyses, and fixed treatment order limit broad conclusions. The study supports a conditional benefit, not universal enhancement. [2]
Kirkpatrick and colleagues compared intranasal methamphetamine, dextroamphetamine, and placebo in 13 male recreational methamphetamine users. Both drugs improved maximum tracking speed on the divided-attention task; the smaller doses also shortened response latency. No other significant acute performance effects were reported, and no significant residual performance effects were observed. Dextroamphetamine was a comparator, while methamphetamine itself was administered and evaluated. The comparison does not establish that the drugs are interchangeable in every setting. [3]
Ballard and colleagues studied 60 healthy young adults given oral methamphetamine or placebo before or after viewing emotional and neutral images. Memory was tested two days later without drug administration. Among adequate sleepers, 20 mg given before viewing improved recognition accuracy, particularly for emotional images. In poor sleepers, pre-viewing administration impaired memory. Giving the drug only after viewing did not improve memory. The sleep groups were defined using reported sleep after the higher dose, making that subgroup context essential to interpretation. [4]
Tracking speed, response latency, working-memory accuracy, and later recognition of pictures are different outcomes. A benefit in one cannot automatically answer a question about another. “Improved performance” should always be followed by an explanation of what was measured.
These studies also distinguish an objective test result from feeling more energetic or alert. For a research claim, the relevant evidence is the measured outcome against the study’s comparison condition.
These findings provide a basis for questioning an absolute claim that methamphetamine invariably worsens every cognitive or psychomotor function. They do not establish that a particular person drove safely, exercised sound judgment, or was unimpaired at a particular time. That is a separate, case-specific question.
A useful review asks which task is relevant, how closely the person resembles the study population, whether the route and timing are comparable, and whether the claimed benefit appeared in the whole sample or only a subgroup. Those questions preserve the strength of the affirmative evidence without extending it beyond what the researchers measured.
The defensible conclusion is specific: acute methamphetamine administration has improved selected human performance measures under controlled conditions. The scope of each finding is defined by the experiment that produced it.